Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade nam…
Insulin
Eli Lilly Announces The First 300-Unit Vial of Insulin
Eli Lilly and Company announced the availability of a smaller vial of insulin containing 3 mL (300 units), the first suc…
Novo Nordisk Starts Phase 1 Trial With Oral Insulin
Novo Nordisk announced today that it has initiated its first phase 1 clinical trial with an oral insulin analogue (NN195…
Novo Nordisk: Progress Made in Oral Insulin Development
Lars Sorensen, Novo's chief executive, speaking at the Reuters Health Summit, said the company could introduce a oral in…
